This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.
Cardiovascular diseases, including arrhythmias, are a growing health concern in sub-Saharan Africa. A recent study in JACC: Clinical Electrophysiology highlights this issue and explores AI-powered solutions. Most studies in the region rely on standard ECGs, which do not capture transient arrhythmias.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. Jennifer Currin, Ph.D.,
Abstract Introduction The increasing use of insertable cardiac monitors (ICMs) for long-term continuous arrhythmia monitoring creates a high volume of transmissions and a significant workload for clinics.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Physician-mapper interactions were quantified and classified as high- versus low-quality communications (high quality directly impacted navigation, medical decision-making, or patientcare). BACKGROUND:The CommandEP system v2 (Sentiar, St.
During the event, to take place at the Signia by Hilton Atlanta, innovators will gather in one room throughout the conference, gaining insights into regulatory approvals, clinical trials, market adoption, and the integration of novel technologies into patientcare. On Thursday, Sept.
In response, an increasing number of clinics have chosen to rely on cardiac remote patient monitoring ( RPM ) software. This software is transforming preventative healthcare, as it optimizes clinic management and improves patientcare. What’s Next in Cardiac Remote Patient Monitoring Software ?
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. 1 Approximately 33 million patients worldwide are living with AFib.
The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias—abnormal heartbeats that start in the heart’s two lower chambers—and an elevated risk of sudden cardiac death in patients with mitral valve disease.
To improve arrhythmogenic cardiomyopathy (ACM) patientcare four pillars of ACM research are necessary. Third, preclinical gene studies can improve ACM patientcare to determine which vector has the optimal effect in which specific gene for gene therapy.
The patient advised overall improvement with complete resolution of symptoms. The patientcare narrative states no further changes in heart rate with persistent LBBB morphology. Chapter 17: Ventricular Arrhythmias. Josephson’s Clinical Cardiac Electrophysiology: Techniques and Interpretations (6th ed).
Finally, much of this correlates well with The new Canadian Syncope Arrhythmia Risk Score , just published in 2016, results of which are given below in the Annotated Bibliography. The most recent and probably best study is this: Canadian Syncope Arrhythmia Risk Score. Vasovagal syncope is generally benign. Thiruganasambandamoorthy, V.,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content